Interestingly, CDKN1A was computed to be an important nexus gene between the panels “insulin resistance” - “ROS” - “mammary adenocarcinoma”, with an induced expression at day 21 and day 28 (2.3-fold, p<0.00001). The gene discussed is CDKN1A; the disease is breast adenocarcinoma.